XBiotech Inc. — Director's Dealing 2021

Sep 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2021-09-20

Reporting Person: SIMARD JOHN (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-20	Common Stock	S	13471	$15.063	Disposed	4159695	Direct
2021-09-21	Common Stock	S	16860	$15.238	Disposed	4142835	Direct
2021-09-22	Common Stock	S	19669	$15.1384	Disposed	4123166	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.